Gorczynski R M, Fu X M, Issekutz T, Cohen Z
Department of Surgery, University of Toronto Transplant Research, Ontario, Canada.
Cell Immunol. 1998 Feb 25;184(1):74-82. doi: 10.1006/cimm.1998.1260.
Female Lewis (LEW) rats received orthotopic small intestinal transplantation (SIT), or tail skin grafts from female (Lewis x Brown Norway)F1 (LBNF1) rats, along with peritransplant portal venous (pv) infusion of LBNF1 bone marrow-derived dendritic cells derived from male donors. All animals received im injection with cyclosporin A (5 mg/kg) for 3 consecutive days following transplantation. In some cases rats received intravenous injections, at 2-day intervals, with 1 mg of monoclonal antibodies to ICAM-1 or the integrins alpha 4, alpha L, or beta 2, or combinations of these reagents. Cells were harvested from the recipient rats at different times posttransplantation, and single cell suspensions were analyzed by FACS for expression of CD3+, CD4+, CD8+, alpha beta TcR+, and gamma delta TcR+ cells. Other tissue samples were used for histopathological assessment of rejection. We also investigated donor-specific and third-party (Wistar-Furth, Wi) restimulation of host lymphocytes from MLN, PLN, and PP for production of different cytokines in vitro. Of the various antibodies tested, only anti-alpha 4, but not anti-alpha L, -beta 2, nor -ICAM-1 led to further increased graft survival of LBNF1 SIT beyond that seen with pv-infused cells alone (30 days vs 19 days), while the combination of anti-alpha L (or beta 2) and ICAM-1 produced further significantly increased survival of skin grafts (30 days vs 21 days). For both SIT and skin-grafted animals increased graft survival was associated with decreased production of IL-2 and IFN-gamma and increased production of IL-4 and IL-10 from tissues local to the graft (PP and draining LN, respectively), with less significant alterations in tissues distant to the graft (PLN for SIT, and MLN for skin grafts). While, as reported previously, pv-immunized SIT rats showed increased gamma delta TCR+ cells within the SIT in association with increased graft survival, treatment with anti-alpha 4 diminished this increase in gamma delta TCR+ cells, while simultaneously increasing SIT survival. Nevertheless, the bias toward increased IL-10 production, and decreased IFN-gamma production, from cells of animals showing increased survival was maintained. These data suggest that local graft infiltration with gamma delta TCR+ cells following pv immunization is not necessary for prolongation of survival in this model system, although functional changes in the local cytokines milieu may be important.
雌性Lewis(LEW)大鼠接受原位小肠移植(SIT),或接受来自雌性(Lewis×Brown Norway)F1(LBNF1)大鼠的尾部皮肤移植,并在移植周围门静脉(pv)输注来自雄性供体的LBNF1骨髓来源的树突状细胞。所有动物在移植后连续3天接受环孢素A(5mg/kg)的肌肉注射。在某些情况下,大鼠每隔2天静脉注射1mg抗ICAM-1或整合素α4、αL或β2的单克隆抗体,或这些试剂的组合。在移植后不同时间从受体大鼠中采集细胞,通过流式细胞术分析单细胞悬液中CD3+、CD4+、CD8+、αβTcR+和γδTcR+细胞的表达。其他组织样本用于排斥反应的组织病理学评估。我们还研究了来自肠系膜淋巴结(MLN)、腹股沟淋巴结(PLN)和派氏结(PP)的宿主淋巴细胞对供体特异性和第三方(Wistar-Furth,Wi)的再刺激,以在体外产生不同的细胞因子。在测试的各种抗体中,只有抗α4抗体,而不是抗αL、抗β2或抗ICAM-1抗体,能使LBNF1 SIT的移植物存活时间比单独输注pv细胞时进一步延长(30天对19天),而抗αL(或β2)和ICAM-1的组合可使皮肤移植物的存活时间进一步显著延长(30天对21天)。对于SIT和皮肤移植动物,移植物存活时间的延长与移植物局部组织(分别为PP和引流淋巴结)中IL-2和IFN-γ的产生减少以及IL-4和IL-10的产生增加有关,而在远离移植物的组织(SIT为PLN,皮肤移植为MLN)中变化不太明显。虽然如先前报道的那样,pv免疫的SIT大鼠的SIT内γδTCR+细胞增加与移植物存活时间延长有关,但用抗α4治疗可减少γδTCR+细胞的这种增加,同时提高SIT的存活时间。然而,存活时间增加的动物细胞中IL-10产生增加和IFN-γ产生减少的倾向仍然存在。这些数据表明,在该模型系统中,pv免疫后γδTCR+细胞局部浸润移植物对于延长存活时间并非必需,尽管局部细胞因子环境的功能变化可能很重要。